Treatment with an antisense oligodeoxynucleotide to the GABAA receptor gamma 2 subunit increases convulsive threshold for beta-CCM, a benzodiazepine "inverse agonist', in rats.
The gamma 2 subunit of the gamma-aminobutyric acid type-A (GABAA) receptor is associated with the actions of benzodiazepines and related drugs. A phosphorothioate-modified antisense oligodeoxynucleotide directed against the gamma 2 subunit was given by i.c.v. injection (18 micrograms in 2 microliters saline) to male Sprague-Dawley rats every 12 h for 3 days. Controls received the corresponding sense oligodeoxynucleotide. 4-6 h after the last i.c.v. treatment, rats were given methyl-beta-carboline-3-carboxylate (beta-CCM), a benzodiazepine "inverse agonist', by slow i.v. infusion. Compared to naive rats, the beta-CCM threshold dose was not affected by the sense oligodeoxynucleotide, but was increased 87% in antisense oligodeoxynucleotide-treated rats. The treatment had no effect on the seizure threshold for picrotoxin. Both antisense and sense oligodeoxynucleotide treatments slightly increased the threshold for strychnine seizures. The results suggest that antisense oligodeoxynucleotide treatment altered GABAA receptor composition and interfered with the actions of a benzodiazepine receptor ligand in vivo, and may provide a tool for studying regulation of receptor structure and function.
Zhao
T J
TJ
Department of Pharmacology, Medical College of Ohio, Toledo 43699, USA.
Rosenberg
H C
HC
Chiu
T H
TH
D000704:Analysis of Variance; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002243:Carbolines / Q000378:metabolism / Q000494:pharmacology*; D003292:Convulsants / Q000378:metabolism / Q000494:pharmacology*; D007276:Injections, Intraventricular; D008297:Male; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D010852:Picrotoxin / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D011963:Receptors, GABA-A / Q000737:chemistry / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D012640:Seizures; D013331:Strychnine / Q000494:pharmacology
D002243:Carbolines; D003292:Convulsants; D016376:Oligonucleotides, Antisense; D010852:Picrotoxin; D012333:RNA, Messenger; D011963:Receptors, GABA-A; D013331:Strychnine; C036150:beta-carboline-3-carboxylic acid methyl ester